After a pharma lobbying blitz, Congress softens legislation on drug patents
The Health 202: The Supreme Court banned patenting genes. But Congress might change that.
Cornyn to launch bill against ‘patent thickets’
Senate Targets Hoarding of Drug Patents to Deter Competition
Costs for lifesaving drugs have skyrocketed. Experts say ‘over-patenting’ to prevent generic competition is part of the problem
Examining the Truvada #BreakThePatent Debate: Gilead Responds
Why Abbvie May Have A Tough Time Defending Humira’s Price Before Congress
It’s Time for Pharmaceutical Companies to Have Their Tobacco Moment
Bringing the medicine access fight to the US
Beyond “Capacity Building”: Crafting Partnerships Based on Equality